Chemours donations raise questions about Whatley | Opinion
Emily Donovan and Jessica Cannon, co-founders of Clean Cape Fear, criticize U.S. Senate candidate Michael Whatley for accepting campaign donations from Chemours. They allege Whatley has not supported PFAS regulations or held Chemours accountable for pollution, citing his support for budget cuts that delayed cleanup at Seymour Johnson Air Force Base. The authors contrast Whatley's stance with Governor Roy Cooper's commitment to fighting corporate polluters.
Chemours Launches Two Low-GWP Opteon Refrigerants For Chillers
Chemours has introduced two new low-GWP Opteon refrigerants, Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B), aimed at supermarket chillers and other commercial cooling applications. These refrigerants are designed to help businesses comply with stricter environmental regulations while improving energy efficiency and supporting sustainability efforts. They are suitable for various stationary cooling needs, including data centers, and are currently available in strategic countries with plans for expanded market availability.
Chemours president Martinko buys $30,008 in company stock
Joseph T. Martinko, President of Thermal & Specialized Solutions at The Chemours Company, recently purchased 1,939.8014 shares of company stock for $30,008. This insider transaction occurred on August 7, 2026, and increases his direct ownership to 55,431.4012 shares. The purchase follows mixed Q2 2026 results for Chemours, an analyst downgrade by UBS, and a 22% stock decline over the past six months, even as analysts predict a return to profitability.
Chemours co president Michael Foley buys $29,999 in stock
Michael Foley, President of Titanium Technologies at The Chemours Company, recently purchased 1,934.2313 shares of the company's common stock for $29,999. This insider transaction occurred on August 7, 2026, and increased his direct holdings to 80,777.2308 shares. Despite the insider purchase, Chemours stock is down 22% over the past six months, though up 36% year-to-date, and is considered slightly overvalued by InvestingPro analysis.
Chemours president Martinko buys $30,008 in company stock
Joseph T. Martinko, President of Thermal & Specialized Solutions at The Chemours Company, recently purchased 1,939.8014 shares of the company's common stock for $30,008. This insider acquisition comes after Chemours reported mixed Q2 2026 results, missing analyst forecasts, and faced a downgrade from UBS due to concerns about its refrigerant business. Despite the recent stock decline and analyst downgrade, InvestingPro analysis suggests Chemours trades above its Fair Value, with analysts predicting a return to profitability this year.
Chemours co president Michael Foley buys $29,999 in stock
Michael Robert Foley, President of Titanium Technologies at The Chemours Company, recently purchased $29,999 worth of company stock, acquiring 1,934.2313 shares. This insider purchase comes after Chemours reported Q2 2026 earnings below expectations and received a downgrade from UBS due to concerns about its refrigerant business. Despite a recent 22% drop over six months, the stock is up 36% year-to-date.
How Investors Are Reacting To Chemours (CC) Expanding Low-GWP Opteon Refrigerants For AI Data Centers
Chemours recently launched new ultra-low and low-GWP Opteon refrigerants for AI data centers, aiming for higher-value, climate-focused applications. While this expands their market reach, the company faces headwinds from weaker Opteon aftermarket demand, ongoing losses, and PFAS liabilities, leading to an updated 2026 net loss outlook. Despite a projected $24.67 fair value and 56% upside, investors must weigh the long-term growth potential against current financial challenges and unresolved litigation.
Analysts Offer Insights on Materials Companies: Chemours Company (CC), Pan American Silver (PAAS) and West Fraser Timber Co (WFG)
BMO Capital analysts have provided ratings for several materials companies. John McNulty maintained a Buy rating on Chemours Company (CC) with an $18.00 price target. Matt Murphy issued a Hold rating for Pan American Silver (PAAS) with a C$75.00 price target, and Ketan Mamtora reiterated a Buy rating on West Fraser Timber Co (WFG) with a $90.00 price target.
Chemours Expands Low-GWP Refrigerant Portfolio for Data Centers
Chemours has expanded its portfolio of low-GWP refrigerants, Opteon ZE (R-1234ze(E)) and Opteon 515B (R-515B), specifically for stationary chiller applications in data centers. This move aims to address the increasing cooling demands driven by AI technology and reinforce Chemours' position in cooling markets. The company's focus on environmentally sustainable solutions and its strong intellectual property in fluorochemicals are expected to drive future growth.
Chemours Jumps 5.4% After JP Morgan Maintains Neutral
The Chemours Company (NYSE:CC) saw its shares jump 5.4% despite three major Wall Street firms cutting their price targets. JP Morgan, BMO Capital, and UBS all revised their outlooks, with JP Morgan maintaining a Neutral rating and lowering its target to $15. The market reaction suggests investors may have already factored in the downward revisions or see potential upside from the new targets.
Analysts Offer Insights on Materials Companies: Chemours Company (CC), Pan American Silver (PAAS) and West Fraser Timber Co (WFG)
BMO Capital analysts have provided ratings for three materials companies: Chemours Company (CC), Pan American Silver (PAAS), and West Fraser Timber Co (WFG). John McNulty maintained a Buy rating on Chemours with an $18 price target, while Matt Murphy set a Hold rating on Pan American Silver with a C$75 price target. Ketan Mamtora maintained a Buy rating on West Fraser Timber Co, setting a price target of $90.
Chemours president Gerardo Familiar buys $30,050 in stock
Gerardo Familiar Calderon, President of Advanced Performance Materials at The Chemours Company, recently purchased 1,935 shares of the company's common stock for $30,050. This acquisition follows a nearly 25% drop in the stock price over the past six months and occurs amid mixed Q2 2026 results and a downgrade by UBS due to concerns about the refrigerant business. Analysts predict the company will be profitable this year despite these challenges.
Chemours Co (CC) executive increases holdings with 1,935-share open-market buy
Gerardo Familiar Calderon, President of Advanced Performance Materials at Chemours Co (CC), purchased 1,935 shares of Common Stock at $15.53 per share on August 12, 2026. This transaction increased his total holdings to 58,547.3746 shares, which include directly owned shares, restricted stock units, and dividend equivalent units, with an adjustment for a prior administrative error. The purchase was made in an open-market or private transaction and was not affirmed as being made under a Rule 10b5-1 trading plan.
Chemours Co (NYSE: CC) CAO has 2,426 shares withheld to cover tax on RSU vesting
Chemours Co's Chief Accounting Officer, David Will, reported a Form 4 transaction where 2,426 shares of common stock were withheld to cover tax obligations arising from the vesting of restricted stock units and dividend equivalent units. This transaction, valued at $15.24 per share, was not an open market sale and is exempt from Section 16(b). Following this event, Will's total holdings in Chemours Co are 30,868.097 shares.
California alleges DuPont used spin-off companies to avoid PFAS liability
California's attorney general, Rob Bonta, has updated a 2022 lawsuit against DuPont and its spin-off companies, alleging fraudulent corporate restructuring to avoid PFAS liabilities. The state claims DuPont shifted liabilities to Chemours, a company with fewer assets, through two memoranda of understanding in 2021 and 2025, violating state fraudulent transfer laws. If successful, this case could set a precedent for other states to pursue similar claims against companies attempting to evade environmental liabilities.
Chemours (NYSE:CC) Cut to "Strong Sell" at Zacks Research
Zacks Research has downgraded Chemours (NYSE:CC) from a "strong-buy" to a "strong sell" rating. This downgrade follows Chemours' recent quarterly earnings report where the company missed analyst estimates for both EPS and revenue. Despite the downgrade, other analysts maintain a "Hold" rating with a consensus price target of $21.00, and insider CFO Shane Hostetter recently purchased additional shares.
Gov. Stein, AG Jackson oppose Chemours, EPA 'deal'
North Carolina Governor Josh Stein, Attorney General Jeff Jackson, and DEQ Secretary Reid Wilson have voiced strong opposition to a proposed settlement between the EPA and Chemours regarding PFAS contamination. They argue the deal was brokered without consulting North Carolina, offers minimal benefits to its residents, and fails to adequately address the extensive environmental damage caused by Chemours. State officials are urging a federal court to reject the settlement and involve North Carolina in developing a more equitable resolution.
Chemours Co (CC) director Cranston purchases 6,000 shares in open-market trade
Chemours Co director Mary B. Cranston purchased 6,000 shares of common stock at $15.825 per share on August 7, 2026, in an open-market transaction. Following this purchase, her beneficial ownership of Chemours common stock increased to 113,140.9469 shares, which includes directly owned shares, restricted stock units, and dividend equivalent units. The transaction is detailed in a Form 4 SEC filing, indicating a positive sentiment for the company's stock.
Chemours launches two refrigerants for data center chillers
Chemours has introduced two new low-GWP refrigerants, Opteon ZE and Opteon 515B, designed for data center chillers and other large-scale cooling applications. These products aim to provide environmentally friendly alternatives for companies transitioning from higher global warming potential refrigerants. The company emphasizes the importance of these solutions in meeting the evolving cooling demands of AI and data center infrastructure while ensuring efficiency and regulatory compliance.
Chemours Stock Moves as Narrow Q2 Net Loss Offsets Missed Earnings Estimates
Chemours (CC) stock saw movement after reporting a narrower net loss of $274 million in Q2, an improvement from the previous year, despite missing adjusted earnings and revenue estimates. The company's segment results were mixed, with growth in Titanium Technologies and Performance Solutions (driven by AI infrastructure demand), but declines in Thermal & Specialized Solutions and Advanced Performance Materials. Chemours also launched new refrigerant products for data centers and projects Q3 adjusted EBITDA between $175 million and $205 million, with full-year 2026 sales growth of 1% to 5%.
Chemours Co (CC) CFO Shane Hostetter Buys 3,350 Shares
Chemours Co's CFO, Shane Hostetter, recently purchased 3,350 shares of the company stock, signaling strong insider confidence. This transaction, executed at $14.94 per share, increases his direct ownership to over 102,000 shares. The stock is currently deemed "Modestly Undervalued" by GuruFocus's GF Value model, suggesting a potential attractive entry point for investors.
Chemours (NYSE:CC) CFO Shane Hostetter Buys 3,350 Shares
Chemours (NYSE:CC) CFO Shane Hostetter recently purchased 3,350 shares of the company's stock for $50,049, increasing his holdings by 3.37%. This transaction occurred as Chemours reported quarterly adjusted EPS and revenue below analyst consensus, with shares trading near $14.52. Despite the earnings miss, analysts maintain a "Moderate Buy" rating with an average price target of $21.00, and the company has declared a quarterly dividend of $0.0875 per share.
Chemours Co (NYSE: CC) CFO purchases 3,350 shares in open-market trade
Chemours Co's Chief Financial Officer, Shane Hostetter, purchased 3,350 shares of common stock on August 6, 2026, at a price of $14.94 per share. This transaction increased his total beneficial ownership to 102,697.7058 shares, including restricted stock units and dividend equivalent units. The purchase was an open-market transaction and was not made under a Rule 10b5-1 trading plan.
The Chemours Company Launches Opteon Ze and Opteon 515B Refrigerants for Chiller Applications
The Chemours Company has introduced two new low-global warming potential (GWP) refrigerants, Opteon ZE and Opteon 515B, for stationary chiller applications. These products are designed to meet the increasing cooling demands of large-scale infrastructure, including data centers, driven by the growth of AI and cloud computing. The refrigerants offer efficient heat removal, reliable performance, scalability, and support decarbonization goals.
Chemours Company (The) Stock 12‑Month Price Target Cut to $22.5, Implies 43% Upside
Analysts have cut the average 12-month price target for Chemours Company (The) stock to $22.5 from $22.8, with forecasts ranging from $18 to $30 per share. This new target implies a potential upside of approximately 43% based on the recent closing price. The consensus rating for the stock remains a "Buy" from 11 analysts.
Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments
Chemours has launched two new low-global warming potential (GWP) refrigerants, Opteon™ ZE and Opteon™ 515B, designed for chiller applications in data centers, commercial buildings, and other critical environments. These products aim to address the increasing cooling demands of AI and digital infrastructure by offering efficient, reliable, and scalable solutions that support decarbonization goals. Chemours emphasizes its unique position to supply these refrigerants, leveraging its extensive fluorochemicals expertise and intellectual property.
Don't Buy The Chemours Company (NYSE:CC) For Its Next Dividend Without Doing These Checks
The Chemours Company (NYSE:CC) is set to trade ex-dividend soon, with a payment of US$0.0875 per share, resulting in a 2.2% trailing yield. While the dividend is well-covered by free cash flow (25% payout), the company reported a loss last year and has shown declining earnings over the past five years, raising concerns about the long-term sustainability of its dividend despite its historical growth. Investors are cautioned to consider these risks before buying for the dividend.
Chemours Company (The) Stock 12‑Month Price Target Cut to $22.5, Implies 43% Upside
The average 12-month price target for Chemours Company (The) stock has been revised down to $22.5 from $22.8, based on estimates from 10 analysts. This updated target suggests a potential upside of approximately 43% from the August 7 closing price. Despite the target cut, the consensus rating for CC remains a "Buy" among 11 analysts.
The Chemours Company
A federal judge has approved over $2.5 billion in settlements between New Jersey and several companies, including DuPont, Chemours, Corteva, and 3M. These settlements aim to resolve claims related to pollution caused by PFAS, commonly known as "forever chemicals." The Chemours Company was specifically named as one of the entities involved in these legal agreements.
Chemours reports $1.6 billion Q2 2026 sales as cash flow surges & specialty markets gain momentum
The Chemours Company reported Q2 2026 net sales of $1.6 billion, remaining flat year-over-year, with a net loss attributable to the company of $274 million, an improvement from the previous year. The company saw stronger cash generation, a 128% increase in free cash flow, and reduced net leverage, while specialty markets like data centers and semiconductors drove momentum in Advanced Performance Materials. Chemours highlighted disciplined execution, progress on pricing actions in Titanium Technologies, and continued focus on operational discipline and commercial growth for the second half of 2026.
Bonta accuses DuPont of ‘corporate shell game’ to dodge PFAS cleanup in California
California Attorney General Rob Bonta has amended a 2022 lawsuit, accusing DuPont and its spin-off companies of creating a "corporate shell game" to avoid billions in PFAS cleanup costs. The amended complaint alleges that DuPont offloaded massive legal risks onto Chemours, stripping it of valuable assets and leaving it as a "fall guy" unable to pay creditors, including the state of California. Bonta claims this restructuring violates fraudulent transfer acts and seeks to prevent the companies from further moving assets to ensure California receives compensation for widespread PFAS contamination.
First Trust Advisors LP Reduces Stock Holdings in The Chemours Company $CC
First Trust Advisors LP significantly reduced its stake in The Chemours Company ($CC) by 45.7% in Q1 2026, selling 136,907 shares. This comes as Chemours missed Q2 earnings expectations, reporting $0.42 EPS against a $0.49 consensus and revenue of $1.59 billion versus $1.65 billion projected, leading to an 18.3% stock drop. Despite the miss and recent litigation costs, analysts maintain a "Moderate Buy" rating with an average price target of $23.80.
Chemours releases second quarter 2026 results
Chemours reported its Q2 2026 financial results with net sales of approximately USD 1.6 billion, flat compared to the previous year, and a significant 128% year-on-year improvement in free cash flow to USD 114 million. The company recorded a net loss of USD 274 million but saw a 1% rise in Titanium Technologies net sales due to price increases, despite volume declines. Chemours maintains its full-year 2026 outlook for net sales and adjusted EBITDA.
Chemours Company (The) Stock 12‑Month Price Target Cut to $24.9, Implies 39% Upside
The average 12-month price target for The Chemours Company (CC) stock has been lowered slightly from $25.2 to $24.9 by 10 analysts, with individual forecasts ranging from $19 to $30. Based on the August 4th closing price, this updated target suggests a potential upside of approximately 39%. The consensus rating from 11 covering analysts remains a "Buy," comprising 6 Buys, 4 Holds, and 1 Sell recommendation.
Chemours Maintains 2026 Outlook Despite Lower Aftermarket Refrigerant Sales
Chemours reported relatively flat sales in Q2 2026, with net sales at $1.591 billion, a 1% decrease year-over-year. Despite a decline in Opteon refrigerant sales due to normalizing North American aftermarket demand, the company's Thermal & Specialized Solutions segment saw a 3% increase in Adjusted EBITDA, driven by pricing strength. Chemours is maintaining its full-year 2026 guidance, expecting annual net sales growth of 1% to 5% and Adjusted EBITDA between $775 million and $825 million.
Earnings Flash (CC) The Chemours Company Posts Q2 Adjusted EPS $0.42 per Share, Vs. FactSet Est of $0.50
The Chemours Company announced its Q2 adjusted earnings per share of $0.42, falling short of the FactSet estimate of $0.50. This flash report highlights the company's financial performance for the second quarter.
In Cumberland, Whatley taking cash from Chemours not so great | Opinion
The article discusses the controversy surrounding U.S. Senate candidate Michael Whatley accepting a $5,000 donation from Chemours' Political Action Committee. Chemours is a chemical company responsible for PFAS contamination in North Carolina, leading to widespread environmental and health issues. Democratic opponent Roy Cooper has criticized Whatley, tying him to big business interests, and the author suggests returning the money would be a wise political move for Whatley given the company's negative reputation in the region.
Chemours Co earnings missed by $0.08, revenue fell short of estimates
Chemours Co (NYSE: CC) reported second-quarter earnings per share of $0.42, missing analyst estimates by $0.08, and revenue of $1.59 billion, falling short of the $1.66 billion consensus. The company's stock price has declined by 22.18% in the last three months but is up 41.96% over the past year. InvestingPro rates Chemours Co's financial health as "fair performance."
Earnings Flash (CC) The Chemours Company Posts Q2 Adjusted EPS $0.42 per Share, vs. FactSet Est of $0.50
The Chemours Company (CC) reported its Q2 adjusted EPS of $0.42 per share, falling short of the FactSet estimate of $0.50 per share. This financial update follows closely on the heels of the company's Q2 revenue report, which also missed analyst expectations. The announcement highlights recent legal challenges, with New York's Attorney General suing Chemours and other companies over "forever chemicals."
Chemours slides as litigation costs overshadow data center growth (CC:NYSE)
Chemours shares plunged 13% after reporting a narrower quarterly loss but issuing a weak Q3 outlook, signaling seasonal demand weakness in its refrigerants business despite strong demand from data centers. The company continues to face litigation and environmental costs, though it has seen improved free cash flow. Management expects stronger titanium dioxide pricing to partially offset these challenges.
Chemours Announces Third Quarter Dividend
The Chemours Company (NYSE: CC) announced its Board of Directors declared a quarterly cash dividend of $0.0875 per share for the third quarter of 2026. This dividend will be paid on September 15, 2026, to stockholders of record as of August 14, 2026. Chemours is a global leader in industrial and specialty chemicals, serving various markets with products under brands like Opteon, Freon, and Teflon.
Chemours earnings on deck as company faces PFAS settlement costs
Chemours is expected to report significantly improved second-quarter earnings, with analysts forecasting 50 cents per share on $1.66 billion in revenue. Investors will be focused on how the company manages the financial implications of its recent $450 million PFAS settlement, as well as trends in titanium dioxide pricing and demand, and the sustainability of its margin improvements. Despite a "Buy" rating from analysts, recent price target cuts suggest tempered optimism ahead of the earnings release.
North Carolina officials call EPA's $450 million Chemours PFAS settlement a 'sweetheart deal'
North Carolina officials are strongly opposing a proposed $450 million settlement between the EPA and chemical manufacturer Chemours, calling it a "sweetheart deal." They argue the settlement is too lenient on Chemours, which is accused of extensively polluting the Cape Fear River with PFAS "forever chemicals," affecting 500,000 residents and 10,000 private wells. State leaders are demanding that the EPA collaborate with North Carolina to craft a more equitable settlement that specifically benefits the affected residents and addresses the substantial cleanup required.
Chemours, EPA ‘behind our backs’ deal heavily criticized in North Carolina
North Carolina's Governor Josh Stein, Attorney General Jeff Jackson, and DEQ Secretary Reid Wilson are strongly opposing a proposed settlement between the EPA and Chemours regarding PFAS contamination. They claim the deal was negotiated "behind our backs" and does not adequately address the damage done to North Carolina, particularly regarding drinking water and pollution reduction in the state. The officials are urging the federal government to withdraw the settlement, citing its failure to involve the state and provide sufficient benefits to North Carolinians affected by PFAS discharges.
Chemours, EPA ‘behind our backs’ deal heavily criticized in North Carolina
North Carolina's Governor, Attorney General, and Secretary of Environmental Quality are heavily criticizing a proposed $450 million settlement between the EPA and Chemours regarding PFAS contamination. They claim the deal was negotiated "behind our backs," does little to address the decades of damage in North Carolina, and prioritizes Chemours' interests over the state's residents. The officials are urging the federal government to withdraw the settlement, highlighting its failure to include state input, provide adequate drinking water relief for North Carolina, or ensure pollution reduction efforts are focused within the state.
Chemours Company (CC) Q3 2022 Earnings Report - Results, Call & Slides
This article details The Chemours Company's (CC) Q3 2022 earnings results, showing a beat on both EPS and revenue expectations. The company reported actual EPS of $21.63 against a consensus of $18.21, and actual revenue of $31.00 billion exceeding the expected $29.21 billion, marking a 5.77% YoY revenue growth. The report also includes details on the earnings call, an audio recording, and the slide deck from the presentation.
State leaders urge court to reject EPA-Chemours PFAS settlement
North Carolina's top elected officials, including Gov. Josh Stein and Attorney General Jeff Jackson, are urging a federal court to reject a proposed settlement between the U.S. Environmental Protection Agency and Chemours. They argue the agreement fails to adequately protect communities along the Cape Fear River from PFAS contamination, providing little benefit to North Carolina despite decades of pollution from Chemours' Fayetteville Works facility. State leaders contend North Carolina was excluded from negotiations and that the deal offers little beyond existing state requirements, while requesting the EPA work with the state on a more effective agreement.
Gov. Stein rips Chemours-EPA PFAS settlement; company responds
North Carolina Governor Josh Stein, along with the Attorney General and Department of Environmental Quality, has publicly opposed a proposed PFAS settlement between the EPA and Chemours. Stein argues the settlement does little for North Carolinians and fails to hold Chemours accountable for past contamination. Chemours responded by stating it has already invested significant funds in North Carolina to reduce PFAS emissions and mitigate impacts.
US groups tell EPA to reject fast-tracked data center PFAS, warn it would pollute nearby areas
A coalition of 17 environmental groups, led by Earthjustice, is urging the EPA to reject Chemours' application for Opteon 2P50, a PFAS-based coolant intended for data center cooling. They argue that Chemours' science is flawed, minimizing the chemical's harm and warming potential, and that the company is trying to benefit from expedited reviews. Critics are concerned about the health effects of PFAS, nicknamed "forever chemicals," and the potential for increased contamination in surrounding areas and for workers, especially as many Americans already face PFAS contamination in drinking water.
NC leaders balk at chemical company’s proposed deal over PFAS in river
North Carolina Governor Josh Stein, Attorney General Jeff Jackson, and DEQ Secretary Reid Wilson are opposing a proposed deal between the EPA and Chemours regarding PFAS contamination in the Cape Fear River. They argue the settlement, which includes a $22.5 million penalty and $90 million for mitigation over 15 years, does "almost nothing" for North Carolina. State officials claim the deal excludes North Carolina from negotiations, doesn't guarantee funds will be spent in the state, and offers insufficient pollution reduction given Chemours' decades of alleged contamination.
